methotrexate has been researched along with Weight Loss in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (5.56) | 18.7374 |
| 1990's | 10 (27.78) | 18.2507 |
| 2000's | 9 (25.00) | 29.6817 |
| 2010's | 11 (30.56) | 24.3611 |
| 2020's | 4 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Fang, Q; Huang, X; Ouyang, D; Rao, T; Tan, Z; Zeng, X; Zhou, L | 1 |
| da Silva Ferreira, AR; Harmsen, HJM; Havinga, R; Lichtenberg Cloo, S; Tissing, WJE; Vermeij, WP; Wardill, HR | 1 |
| Haberstroh, WD; Lenka, A; Triano, MJ; Whelton, SA | 1 |
| Aslan, K; Azizoglu, ZB; Deniz, K; Erdem, S; Haliloglu, Y; Karakukcu, M; Patiroglu, T; Per, S; Suna, PA; Tasdemir, A; Unal, E; Yay, AH; Yilmaz, E | 1 |
| Epafra, E; Janabi, M; Kazahura, P; Lyimo, F; Nicholaus, P; Pallangyo, P | 1 |
| Adelowo, O; Anaba, EL; Ekeigwe, NL; Olaosebikan, H | 1 |
| Oberhofer, E | 1 |
| Abraham, P; Isaac, B; Kolli, VK; Natarajan, K; Selvakumar, D | 1 |
| Baker, JF; Cannon, GW; Caplan, L; Haroldsen, C; Ibrahim, S; Mikuls, TR | 1 |
| Araújo, TE; Borba, PB; da Silva, AI; de Araújo Júnior, RF; de Araújo, AA; de Souza, FH; Nogueira, AC; Saldanha, TS | 1 |
| Bayat, N; Bükücü, N; Sencar, L; Tarakçioğlu, M; Yüncü, M | 1 |
| Gao, HF; Li, LF; Liu, ZH; Shen, T; Shi, CJ; Wen, XS; Xian, CJ; Xu, XK | 1 |
| Bauerova, K; Jurcovicova, J; Rovensky, J; Scsukova, S; Stancikova, M; Svik, K | 1 |
| Hawks, RG; Meza, JL; Post-White, JE; Sacks, N; Seibel, NL; Smith, LM; Withycombe, JS | 1 |
| El-Haddad, B; Hammoud, D; Shahouri, S; Shaver, T | 1 |
| Del Giglio, M; Girolomoni, G; Gisondi, P; Tessari, G | 1 |
| Ameloot, K; De Wever, W; Goffin, K; Palmers, PJ; Voigt, JU | 1 |
| Bertino, JR; Chabner, BA; Johns, DG | 1 |
| Balthasar, JP; Lobo, ED | 1 |
| Balthasar, JP; Lobo, ED; Soda, DM | 1 |
| Araujo, DH; Brito, GA; Carneiro-Filho, BA; Carvalho, GH; Cavalcante, MC; Lima, AA; Lima, IP; Lima, V; Monteiro, SM; Ribeiro, RA; Santos, FN | 1 |
| Chau, Y; Dang, NM; Langer, R; Padera, RF | 1 |
| Celik, A; Eralp, A; Yüncü, M | 1 |
| Arakawa, Y; Hirotani, Y; Ikeda, K; Kitamura, K; Kurokawa, N; Li, J; Tanaka, K; Yamamoto, K | 1 |
| Baracos, VE; Cynober, L; Gugins, S; Le Bricon, T | 1 |
| Chevreau, N; Funk-Archuleta, M | 1 |
| Catsoulakos, P; Karakiulakis, G; Pispirigos, K | 1 |
| Black, KW; Prielipp, R; Roberts, P; Zaloga, GP | 1 |
| Kadin, ME; Sajjadian, A; Vonderheid, EC | 1 |
| Gilchrist, GS; O'Marcaigh, AS | 1 |
| Higuchi, S; Inoue, K; Nakano, S; Ogawa, N; Ohdo, S; Yukawa, E | 1 |
| Akman, RY; Arikan, AY; Can, C; Senel, FM | 1 |
| Frerichs, J; Hoijer, M; Jager, D; Koetsier, M; M'Rabet, L; Meijer, HP; Smeets, RL; van't Land, B | 1 |
| Eagan, RT; Feldman, ER; Schaid, DJ | 1 |
| Bortnowski, HB; Rosenthal, RC | 1 |
| Allum, WH; Hallissey, MT; Kelly, KA | 1 |
2 trial(s) available for methotrexate and Weight Loss
| Article | Year |
|---|---|
Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study.
Topics: Adult; Aged; Body Mass Index; Dermatologic Agents; Diet, Reducing; Female; Humans; Male; Methotrexate; Middle Aged; Obesity; Psoriasis; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Treatment Outcome; Weight Loss | 2012 |
Adjuvant chemotherapy in operable gastric cancer. 5 year follow-up of first British Stomach Cancer Group trial.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; England; Female; Fluorouracil; Follow-Up Studies; Gastrectomy; Humans; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Multicenter Studies as Topic; Neoplasm Staging; Prognosis; Random Allocation; Stomach Neoplasms; Vincristine; Wales; Weight Loss | 1989 |
34 other study(ies) available for methotrexate and Weight Loss
| Article | Year |
|---|---|
Leucovorin ameliorated methotrexate induced intestinal toxicity via modulation of the gut microbiota.
Topics: Animals; Bifidobacterium; Colon; DNA, Bacterial; Gastrointestinal Microbiome; Intestinal Diseases; Leucovorin; Male; Methotrexate; Mice; Mice, Inbred BALB C; RNA, Ribosomal, 16S; Weight Loss | 2020 |
Pre-therapy fasting slows epithelial turnover and modulates the microbiota but fails to mitigate methotrexate-induced gastrointestinal mucositis.
Topics: Animals; Bacteria; Cell Proliferation; Citrulline; Enterocytes; Fasting; Feces; Gastrointestinal Microbiome; Gastrointestinal Tract; Intestinal Mucosa; Jejunum; Lactobacillus; Male; Methotrexate; Mucositis; Rats; Rats, Wistar; Weight Loss | 2020 |
Relapsed granulomatosis with polyangiitis with panhypopituitarism.
Topics: Adrenal Insufficiency; Androgens; Diabetes Insipidus; Fatigue; Glucocorticoids; Granulomatosis with Polyangiitis; Hormone Replacement Therapy; Humans; Hypogonadism; Hypopituitarism; Hypothyroidism; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Pituitary Diseases; Pituitary Gland; Recurrence; Rhinitis; Sella Turcica; Sinusitis; Testosterone; Thyroxine; Weight Loss | 2021 |
Therapeutic effects of vitamin D and IL-22 on methotrexate-induced mucositis in mice.
Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Gene Transfer Techniques; Inflammation Mediators; Interleukin-22; Interleukins; Intestinal Mucosa; Methotrexate; Mice; Mice, Inbred BALB C; Mucositis; Vitamin D; Weight Loss | 2022 |
Bilateral ocular ischemia-induced blindness as a presenting manifestation of Takayasu arteritis: a case report.
Topics: Anti-Inflammatory Agents; Aspirin; Blindness; Computed Tomography Angiography; Dexamethasone; Female; Humans; Methotrexate; Optic Neuropathy, Ischemic; Quality of Life; Takayasu Arteritis; Treatment Outcome; Weight Loss; Young Adult | 2017 |
Eosinophilic granulomatosis with polyangiitis in a Nigerian woman.
Topics: Antibodies, Antineutrophil Cytoplasmic; Edema; Female; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Leg Ulcer; Methotrexate; Middle Aged; Nigeria; Treatment Outcome; Weight Loss | 2019 |
[Weight loss as the alpha and omega. New EULAR recommendations for hip and knee arthrosis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Combined Modality Therapy; Exercise; Feeding Behavior; Humans; Methotrexate; Osteoarthritis, Hip; Osteoarthritis, Knee; Patient Education as Topic; Shoes; Weight Loss | 2013 |
Mitochondrial dysfunction and respiratory chain defects in a rodent model of methotrexate-induced enteritis.
Topics: Animals; Cell Survival; Disease Models, Animal; Electron Transport; Electron Transport Chain Complex Proteins; Enteritis; Enterocytes; Intestine, Small; Male; Methotrexate; Mitochondria; Mitochondrial Diseases; Peroxynitrous Acid; Rats, Wistar; Reactive Oxygen Species; Superoxide Dismutase; Time Factors; Weight Loss | 2014 |
Predictors of longterm changes in body mass index in rheumatoid arthritis.
Topics: Adult; Age Factors; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Body Mass Index; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Hospitals, Veterans; Humans; Linear Models; Male; Methotrexate; Middle Aged; Predictive Value of Tests; Prednisone; Registries; Risk Assessment; Sex Factors; Time Factors; Treatment Outcome; United States; Weight Loss | 2015 |
In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Diarrhea; Disease Models, Animal; Imidazoles; Inflammation; Interleukin-1beta; Intestinal Mucosa; Intestine, Small; Male; Methotrexate; Mucositis; Neoplasms; Olmesartan Medoxomil; Rats, Wistar; Sucrose; Tetrazoles; Tumor Necrosis Factor-alpha; Weight Loss | 2015 |
The effect of vitamin E and L-carnitine against methotrexate-induced injury in rat testis.
Topics: Analysis of Variance; Animals; Antioxidants; Carnitine; Male; Malondialdehyde; Methotrexate; Rats; Rats, Wistar; Superoxide Dismutase; Testicular Diseases; Vitamin B Complex; Vitamin E; Weight Loss | 2015 |
Steamed root of Rehmannia glutinosa Libosch (Plantaginaceae) alleviates methotrexate-induced intestinal mucositis in rats.
Topics: Animals; Disease Models, Animal; Female; Glutathione; Intestinal Mucosa; Methotrexate; Mucositis; Plant Preparations; Plant Roots; Plantaginaceae; Rats; Rats, Wistar; Rehmannia; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha; Weight Loss | 2016 |
Methotrexate treatment ameliorated testicular suppression and anorexia related leptin reduction in rats with adjuvant arthritis.
Topics: Animals; Anorexia; Arthritis, Experimental; Dose-Response Relationship, Drug; Drug Administration Schedule; Leptin; Male; Methotrexate; Rats; Rats, Inbred Lew; Serum Albumin; Testis; Testosterone; Weight Loss | 2009 |
Weight patterns in children with higher risk ALL: A report from the Children's Oncology Group (COG) for CCG 1961.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Mass Index; Child; Child, Preschool; Cranial Irradiation; Cytarabine; Daunorubicin; Ethnicity; Female; Gastrointestinal Diseases; Glucose Intolerance; Humans; Incidence; Male; Methotrexate; Obesity; Pancreatitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Randomized Controlled Trials as Topic; Retrospective Studies; Risk; Vincristine; Weight Gain; Weight Loss; Young Adult | 2009 |
Malignancy-associated multicentric reticulohistiocytosis.
Topics: Antihypertensive Agents; Antineoplastic Agents; Arthralgia; Atenolol; Combined Modality Therapy; Drug Therapy, Combination; Fatigue; Female; Hand; Histiocytosis, Non-Langerhans-Cell; Humans; Hydrochlorothiazide; Hypertension; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasms, Squamous Cell; Prednisone; Radiography; Weight Loss | 2011 |
An echocardiographic finding leading to the diagnosis of giant cell arteritis.
Topics: Aged; Echocardiography, Transesophageal; Fatigue; Follow-Up Studies; Giant Cell Arteritis; Humans; Methotrexate; Methylprednisolone; Positron-Emission Tomography; Risk Assessment; Syncope; Treatment Outcome; Weight Loss | 2013 |
Enzymatic cleavage of methotrexate provides a method for prevention of drug toxicity.
Topics: Animals; Antineoplastic Agents; Drug-Related Side Effects and Adverse Reactions; gamma-Glutamyl Hydrolase; Half-Life; Hydrolysis; Leucovorin; Leukemia; Male; Methotrexate; Mice; Pseudomonas; Survival Rate; Time Factors; Weight Loss | 1972 |
Pharmacokinetic-pharmacodynamic modeling of methotrexate-induced toxicity in mice.
Topics: Animals; Male; Methotrexate; Mice; Models, Chemical; Weight Loss | 2003 |
Application of pharmacokinetic-pharmacodynamic modeling to predict the kinetic and dynamic effects of anti-methotrexate antibodies in mice.
Topics: Animals; Antibodies, Monoclonal; Computer Simulation; Hybridomas; Male; Methotrexate; Mice; Models, Biological; Models, Chemical; Predictive Value of Tests; Weight Loss | 2003 |
Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis.
Topics: Animals; Antimetabolites, Antineoplastic; Biological Transport; Disease Models, Animal; Dose-Response Relationship, Drug; Duodenum; Eating; Ileum; Intestinal Absorption; Intestinal Mucosa; Jejunum; Male; Methotrexate; Potassium; Rats; Rats, Wistar; Sodium; Stomatitis; Water; Weight Loss | 2004 |
Antitumor efficacy of a novel polymer-peptide-drug conjugate in human tumor xenograft models.
Topics: Animals; Antineoplastic Agents; Carbohydrate Sequence; Cell Line, Tumor; Dextrans; Drug Design; Female; Humans; Immunohistochemistry; Intestine, Small; Ki-67 Antigen; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Methotrexate; Mice; Mice, SCID; Molecular Sequence Data; Molecular Structure; Neoplasms; Peptides; Treatment Outcome; Weight Loss; Xenograft Model Antitumor Assays | 2006 |
Effect of aged garlic extract against methotrexate-induced damage to the small intestine in rats.
Topics: Animals; Diarrhea; Garlic; Intestine, Small; Lactic Acid; Male; Malondialdehyde; Methotrexate; Plant Extracts; Rats; Rats, Wistar; Weight Loss | 2006 |
Correlation between plasma glucagon-like peptide 2 levels and proliferative makers in small intestinal injury in rats induced by methotrexate administration.
Topics: Administration, Oral; Animals; Biomarkers; Cell Proliferation; DNA; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Glucagon-Like Peptide 2; Intestinal Mucosa; Intestine, Small; Membrane Proteins; Methotrexate; Mucositis; Rats; Weight Loss | 2006 |
Negative impact of cancer chemotherapy on protein metabolism in healthy and tumor-bearing rats.
Topics: Animals; Antineoplastic Agents; Cachexia; Cisplatin; Cyclophosphamide; DNA; Eating; Female; Fluorouracil; Intestine, Small; Liver; Liver Neoplasms, Experimental; Methotrexate; Muscle, Skeletal; Nitrogen; Organ Size; Proteins; Rats; Rats, Sprague-Dawley; RNA; Weight Loss | 1995 |
Effect of enteral formulas on methotrexate toxicity.
Topics: Animals; Caseins; Diarrhea; Dietary Fiber; Enteral Nutrition; Food, Formulated; Humans; Male; Methotrexate; Plant Proteins, Dietary; Rats; Rats, Sprague-Dawley; Soybean Proteins; Weight Loss | 1995 |
Evaluation of kidney and liver subacute toxicity of antitumor agents using serum biochemical parameters in rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antineoplastic Agents; Aspartate Aminotransferases; Azasteroids; Blood Glucose; Chemical and Drug Induced Liver Injury; Chlorambucil; Cholesterol; Cisplatin; Epirubicin; gamma-Glutamyltransferase; Kidney; Kidney Diseases; Liver Diseases; Male; Methotrexate; Nitrogen; Nitrogen Mustard Compounds; Potassium; Rats; Rats, Wistar; Sodium; Weight Loss | 1993 |
Gut bacterial translocation/dissemination explains the increased mortality produced by parenteral nutrition following methotrexate.
Topics: Animals; Colony Count, Microbial; Digestive System; Enteral Nutrition; Intestinal Mucosa; Male; Methotrexate; Organ Size; Parenteral Nutrition, Total; Proteins; Rats; Rats, Sprague-Dawley; Weight Loss | 1993 |
Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anemia; Antimetabolites, Antineoplastic; Aspartate Aminotransferases; Dermatologic Agents; Diarrhea; Drug Administration Schedule; Fatigue; Female; Follow-Up Studies; Humans; Ki-1 Antigen; Liver Cirrhosis; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Peripheral; Lymphomatoid Papulosis; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Nausea; Remission Induction; Skin Diseases; Skin Neoplasms; Weight Loss | 1996 |
Dose reduction of chemotherapeutic agents after weight loss.
Topics: Antineoplastic Agents; Body Surface Area; Computer Simulation; Drug Therapy, Computer-Assisted; Humans; Methotrexate; Models, Biological; Weight Loss | 1997 |
Chronotoxicity of methotrexate in mice and its relation to circadian rhythm of DNA synthesis and pharmacokinetics.
Topics: Animals; Antimetabolites, Antineoplastic; Bone Marrow Cells; Circadian Rhythm; DNA; Folic Acid; Leukocyte Count; Male; Methotrexate; Mice; Mice, Inbred ICR; Weight Loss | 1997 |
Comparison of the effects of various anticancer agents on intestinal anastomosis after intraperitoneal administration.
Topics: Analysis of Variance; Anastomosis, Surgical; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cisplatin; Doxorubicin; Fluorouracil; Injections, Intraperitoneal; Intestine, Small; Male; Methotrexate; Rats; Rats, Wistar; Statistics, Nonparametric; Weight Loss; Wound Healing | 1999 |
Transforming Growth Factor-beta2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Atrophy; Cell Cycle; Cell Death; Disease Models, Animal; Epithelial Cells; Female; Immunosuppressive Agents; Intestine, Small; Methotrexate; Rats; Transforming Growth Factor beta; Transforming Growth Factor beta2; Weight Loss | 2002 |
Metastatic bronchioloalveolar carcinoma and metastatic adenocarcinoma of the lung: comparison of clinical manifestations, chemotherapeutic responses, and prognosis.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Humans; Lomustine; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Mitomycin; Pleural Neoplasms; Prednisone; Prognosis; Remission Induction; Risk Factors; Sex Factors; Survival Rate; Triazines; Vincristine; Weight Loss | 1992 |
Preclinical evaluation of L-asparaginase and methotrexate administered at intermediate doses in dogs.
Topics: Animals; Asparaginase; Diarrhea; Dog Diseases; Dogs; Female; Male; Methotrexate; Random Allocation; Vomiting; Weight Loss | 1991 |